Article Details
Retrieved on: 2022-02-26 16:59:37
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Evusheld, which combines the monoclonal antibodies cilgavimab and tixagevimab, was developed by Anglo-Swedish drugmaker AstraZeneca and was ...
Article found on: thegoaspotlight.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here